Genotype-phenotype correlation in tissue models of Brugada syndrome simulating patients with sodium and calcium channelopathies

Heart Rhythm

Volumn 7, Issue 6, 2010, Pages 820-827

  Morita, Hiroshi ^a,b   Zipes, Douglas P ^a   Morita, Shiho T ^a,b   Wu, Jiashin ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Brugada syndrome; Epicardium; Phase 2 reentry; Premature ventricular complex; Ventricular fibrillation

Indexed keywords

ISOPRENALINE; PILSICAINIDE; PINACIDIL; QUINIDINE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; BRUGADA SYNDROME; CALCIUM CHANNELOPATHY; CONTROLLED STUDY; DRUG RESPONSE; ELECTROCARDIOGRAM; ENDOCARDIUM; EPICARDIUM; GENOTYPE PHENOTYPE CORRELATION; HEART MUSCLE POTENTIAL; HEART RIGHT VENTRICLE; HEART VENTRICLE ARRHYTHMIA; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; SIMULATION; SODIUM CHANNELOPATHY; ST SEGMENT ELEVATION; T WAVE; T WAVE ALTERNANS;

ACTION POTENTIALS; ADRENERGIC BETA-AGONISTS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BODY SURFACE POTENTIAL MAPPING; BRUGADA SYNDROME; CALCIUM CHANNEL BLOCKERS; CHANNELOPATHIES; DOGS; ENDOCARDIUM; GENOTYPE; ISOPROTERENOL; LIDOCAINE; MALE; PERICARDIUM; PHENOTYPE; PINACIDIL; SODIUM CHANNELS; TISSUE CULTURE TECHNIQUES; VASODILATOR AGENTS; VERAPAMIL;

EID: 77952551560     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2010.01.039     Document Type: Article

References (41)

1. Brugada P., and Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20 (1992) 1391-1396
2. Martini B., Nava A., Thiene G., et al. Ventricular fibrillation without apparent heart disease: description of six cases. Am Heart J 118 (1989) 1203-1209
3. Chen Q., Kirsch G.E., Zhang D., et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392 (1998) 293-296
4. London B., Michalec M., Mehdi H., et al. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation 116 (2007) 2260-2268
5. Antzelevitch C., Pollevick G.D., Cordeiro J.M., et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115 (2007) 442-449
6. Morita H., Wu J., and Zipes D.P. The QT syndromes: long and short. Lancet 372 (2008) 750-763
7. Priori S.G., Napolitano C., Schwartz P.J., et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 292 (2004) 1341-1344
8. Schwartz P.J., Priori S.G., Spazzolini C., et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103 (2001) 89-95
9. Zhang L., Timothy K.W., Vincent G.M., et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation 102 (2000) 2849-2855
10. Shimizu W. The long QT syndrome: therapeutic implications of a genetic diagnosis. Cardiovasc Res 67 (2005) 347-356
11. Smits J.P., Eckardt L., Probst V., et al. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 40 (2002) 350-356
12. Yokokawa M., Noda T., Okamura H., et al. Comparison of long-term follow-up of electrocardiographic features in Brugada syndrome between the SCN5A-positive probands and the SCN5A-negative probands. Am J Cardiol 100 (2007) 649-655
13. Morita H., Nagase S., Miura D., et al. Differential effects of cardiac sodium channel mutations on initiation of ventricular arrhythmias in patients with Brugada syndrome. Heart Rhythm 6 (2009) 487-492
14. Morita H., Zipes D.P., Morita S.T., Lopshire J.C., and Wu J. Epicardial ablation eliminates ventricular arrhythmias in an experimental model of Brugada syndrome. Heart Rhythm 6 (2009) 665-671
15. Wu J., Biermann M., Rubart M., and Zipes D.P. Cytochalasin D as excitation-contraction uncoupler for optically mapping action potentials in wedges of ventricular myocardium. J Cardiovasc Electrophysiol 9 (1998) 1336-1347
16. Morita H., Kusano K.F., Miura D., et al. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation 118 (2008) 1697-1704
17. Morita H., Zipes D.P., Morita S.T., and Wu J. Temperature modulation of ventricular arrhythmogenicity in a canine tissue model of Brugada syndrome. Heart Rhythm 4 (2007) 188-197
18. Fish J.M., and Antzelevitch C. Role of sodium and calcium channel block in unmasking the Brugada syndrome. Heart Rhythm 1 (2004) 210-217
19. Fish J.M., and Antzelevitch C. Cellular mechanism and arrhythmogenic potential of T-wave alternans in the Brugada syndrome. J Cardiovasc Electrophysiol 19 (2008) 301-308
20. Antzelevitch C., Brugada P., Borggrefe M., et al. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2 (2005) 429-440
21. Shimizu W., Aiba T., and Kamakura S. Mechanisms of disease: current understanding and future challenges in Brugada syndrome. Nat Clin Pract Cardiovasc Med 2 (2005) 408-414
22. Yan G.X., and Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 100 (1999) 1660-1666
23. Aiba T., Shimizu W., Hidaka I., et al. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study. J Am Coll Cardiol 47 (2006) 2074-2085
24. Morita H., Zipes D.P., Fukushima-Kusano K., et al. Repolarization heterogeneity in the right ventricular outflow tract: correlation with ventricular arrhythmias in Brugada patients and in an in vitro canine Brugada model. Heart Rhythm 5 (2008) 725-733
25. Morita H., Zipes D.P., Lopshire J., et al. T wave alternans in an in vitro canine tissue model of Brugada syndrome. Am J Physiol Heart Circ Physiol 291 (2006) H421-H428
26. Fish J.M., Welchons D.R., Kim Y.S., et al. Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome. Circulation 113 (2006) 1393-1400
27. Yasuda M., Nakazato Y., Yamashita H., et al. ST segment elevation in the right precordial leads following administration of class Ic antiarrhythmic drugs. Heart 85 (2001) E3
28. Hisamatsu K., Kusano K.F., Morita H., et al. Relationships between depolarization abnormality and repolarization abnormality in patients with Brugada syndrome: using body surface signal-averaged electrocardiography and body surface maps. J Cardiovasc Electrophysiol 15 (2004) 870-876
29. Morita H., Zipes D.P., Morita S.T., and Wu J. Differences in arrhythmogenicity between the canine right ventricular outflow tract and anteroinferior right ventricle in a model of Brugada syndrome. Heart Rhythm 4 (2007) 66-74
30. Antzelevitch C., and Fish J. Electrical heterogeneity within the ventricular wall. Basic Res Cardiol 96 (2001) 517-527
31. Di Diego J.M., Cordeiro J.M., Goodrow R.J., et al. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation 106 (2002) 2004-2011
32. Yan G.X., and Kowey P.R. ST segment elevation and sudden cardiac death: from the Brugada syndrome to acute myocardial ischemia. J Cardiovasc Electrophysiol 11 (2000) 1330-1332
33. Shimizu W., and Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 98 (1998) 2314-2322
34. Shimizu W., and Antzelevitch C. Differential response of transmural dispersion of repolarization and torsade de pointes to beta-adrenergic agonists and antagonists in three models of the long QT syndrome. J Electrocardiol 32 Suppl (1999) 150
35. Morita S.T., Zipes D.P., Morita H., and Wu J. Analysis of action potentials in the canine ventricular septum: no phenotypic expression of M cells. Cardiovasc Res 74 (2007) 96-103
36. Fujimoto Y., Kusano K.F., Morita H., et al. Nicorandil attenuates both temporal and spatial repolarization alternans. J Electrocardiol 33 (2000) 269-277
37. Cordeiro J.M., Greene L., Heilmann C., et al. Transmural heterogeneity of calcium activity and mechanical function in the canine left ventricle. Am J Physiol Heart Circ Physiol 286 (2004) H1471-H1479
38. Greenstein J.L., Wu R., Po S., et al. Role of the calcium-independent transient outward current I(to1) in shaping action potential morphology and duration. Circ Res 87 (2000) 1026-1033
39. Sun X., and Wang H.S. Role of the transient outward current (Ito) in shaping canine ventricular action potential-a dynamic clamp study. J Physiol 564 (2005) 411-419
40. Yeola S.W., and Snyders D.J. Electrophysiological and pharmacological correspondence between Kv4.2 current and rat cardiac transient outward current. Cardiovasc Res 33 (1997) 540-547
41. Katsube Y., Yokoshiki H., Nguyen L., and Sperelakis N. Differences in isoproterenol stimulation of Ca2+ current of rat ventricular myocytes in neonatal compared to adult. Eur J Pharmacol 317 (1996) 391-400